Time Course Analysis of Serum and Urinary Proteins by SDS-PAGE in Experimental Nephrotic Syndrome

References

• Kaysen GA. Nonrenal complications of the nephrotic syndrome. Annu Rev Med 1994; 45: 201–210
   PubMedGoogle Scholar
• Harris R C, Ismail N. Extrarenal complications of the nephrotic syndrome. Am J Kidney Dis 1994; 23: 477–497
   PubMed Web of Science ®Google Scholar
• Kaysen GA. Plasma composition in the nephrotic syndrome. Am J Nephrol 1993; 13: 347–359
   PubMedGoogle Scholar
• Vaziri ND. Endocrinological consequences of the nephrotic syndrome. Am J Nephrol 1993; 13: 360–364
   PubMed Web of Science ®Google Scholar
• Cameron JS. Clinical consequences of the nephrotic syndrome. Oxford Textbook of Clinical Nephrology. Oxford, Oxford University Press, S Cameron, AM Davison, J-P Grünfeld, D Kerr, E Ritz, 1992; 276–297
   Google Scholar
• Bernard DB. Extrarenal complications of the nephrotic syndrome. Kidney Int 1988; 33: 1184–1202
   PubMed Web of Science ®Google Scholar
• Pedraza-Chaverrí J, Cruz C, Ibarra-Rubio M E, Chávez M T, Calleja C, Tapia E, Uribe M C, Romero L, Penˆa JC. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia and renin-angiotensin-aldosterone system on sodium retention. Rev Invest Clin 1990; 42: 29–38
   PubMedGoogle Scholar
• Lewandowski A E, Liao W SL, Stinson-Fisher C A, Kent J D, Jefferson LS. Effects of experimentally induced nephrosis on protein synthesis in rat liver. Am J Physiol 1988; 254: C634–C642
   Google Scholar
• Beaman M, Oldfield S, Maclennan I CM, Michael J, Adu D. Hypogammaglobulinemia in nephrotic rats is attributable to hypercatabolism in IgG. Clin Exp Immunol 1988; 74: 425–430
   PubMedGoogle Scholar
• Mizokuchi M, Kubota M, Tomino Y, Koide H. Possible mechanism of impaired calcium and vitamin D metabolism in nephrotic rats. Kidney Int 1992; 42: 335–340
   PubMedGoogle Scholar
• Pedraza-Chaverrí J, Cruz C, Tapia E, Penˆa JC. Activity of serum enzymes in puromycin aminonucleoside-induced nephrotic syndrome. Ren Fail 1992; 14: 523–531
   PubMed Web of Science ®Google Scholar
• Pedraza-Chaverrí J, Maciel A H, Cruz C, Penˆa JC. Captopril magnifies the increase in angiotensin I-converting enzyme activity rats with aminonucleoside-nephrosis. Clin Exp Pharmacol Physiol 1992; 19: 439–445
   PubMedGoogle Scholar
• Levy E, Ziv E, Bar-On H, Shafrir E. Chylomicron synthesis in experimental nephrotic syndrome. Biochim Biophys Acta 1989; 1005: 20–26
   PubMedGoogle Scholar
• Zhou X-J, Vaziri ND. Erythropoietin metabolism and pharmacokinetics in experimental nephrosis. Am J Physiol 1992; 263: F812–F815
   Google Scholar
• Yayama K, Konishi K, Ohta A, Takano M, Ohtani R, Ito N, Okamoto H. Elevation of plasma angioten-sinogen in rats with experimentally induced nephrosis. Nephron 1993; 63: 89–93
   PubMedGoogle Scholar
• Cruz C, Juárez-Nicolás F, Tapia E, Correa-Rotter R, Pedraza-Chaverrí J. Abnormalities of coagulation in experimental nephrotic syndrome. Nephron 1994; 68: 489–496
   PubMed Web of Science ®Google Scholar
• Marshall J F, Apostolopoulos J J, Brack C M, Howlett GJ. Regulation of apolipoprotein gene expression and plasma high-density lipoprotein composition in experimental nephrosis. Biochim Biophys Acta 1990; 1042: 271–279
   PubMedGoogle Scholar
• Panduro A, CastrillÓn L, Pedraza-Chaverrí J, Vargas F, Ibarra-Rubio ME. Regulation of apolipoprotein A-l and E gene expression in liver and intestine of nephrotic and pair fed rats. Nephron 1993; 65: 100–107
   PubMedGoogle Scholar
• Mainero A, Cruz C, Pedraza-Chaverrí J. Serum and urinary ceruloplasmin in experimental nephrotic syndrome. Clin Invest Med 1992; 15: 295–300
   PubMedGoogle Scholar
• Yamauchi A, Imai E, Noguchi T, Tanaka T, Yamamoto S, Mikami H, Fukuhara Y, Fujii M, Orita Y, Kamada Y. Albumin gene transcription is enhanced in liver of nephrotic rats. Am J Physiol 1988; 254: E676–E679
   Google Scholar
• Pedraza-Chaverrí J, Torres-Rodrîguez G A, Cruz C, Mainero A, Tapia E, Ibarra-Rubio M E, Silencio JL. Copper and zinc metabolism in aminonucleoside-induced nephrotic syndrome. Nephron 1994; 66: 87–92
   PubMedGoogle Scholar
• Pedraza-Chaverrí J, Cruz C, Ibarra-Rubio M E, Hernández C, Tapia E, Penˆa JC. Urinary excretion of renin and angiotensinogen in nephrotic rats. Nephron 1991; 57: 106–108
   PubMedGoogle Scholar
• Bomhard E, Maruhn D. Effects of puromycin aminonucleoside on ten urinary enzymes in rats. Arch Toxicol 1988; 12: 156–161
   Google Scholar
• Price R G, Ellis BG. Urinary enzyme excretion in aminonucleoside nephrosis in rats. Chem-Biol Interact 1976; 13: 353–358
   PubMedGoogle Scholar
• Pedraza-Chaverrí J, CalderÓn P, Cruz C, Penˆa JC. Electrophoretic analysis of serum and urinary proteins in rats with aminonucleoside-induced nephrotic syndrome. Ren Fail 1993; 15: 149–155
   PubMed Web of Science ®Google Scholar
• Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685
   PubMed Web of Science ®Google Scholar
• Nichols DM. Biosynthesis of renal proteins in aminonucleoside nephrosis. Can J Biochem 1968; 46: 527–535
   PubMedGoogle Scholar
• Dickie N, Alexander C S, Nagasawa HT. Inhibition of nucleic acid synthesis in Escherichia coli B by puromycin aminonucleoside. Biochim Biophys Acta 1965; 95: 156–169
   PubMedGoogle Scholar
• Nathans D, Neidle A. Structural requirements for puromycin inhibition of protein synthesis. Nature 1963; 197: 1076–1077
   PubMed Web of Science ®Google Scholar
• Rabinovitz M, Fisher JM. A dissociative effect of puromycin on the pathway of protein synthesis by Ehrlich ascites tumor cells. J Biol Chem 1962; 237: 477–481
   PubMedGoogle Scholar
• Coers W, Huitema S, van der Horst M LC, Weening JJ. Puromycin aminonucleoside and adriamycin disturb cytoskeletal and extracellular matrix protein organization, but not protein synthesis of cultured glomerular epithelial cells. Exp Nephrol 1994; 2: 40–50
   PubMedGoogle Scholar
• Moscarello M A, Sutherland L, Jackson SH. Stimulation of [14C]glucosamine incorporation into plasma proteins by aminonucleoside. Biochim Biophys Acta 1966; 127: 373–379
   PubMedGoogle Scholar
• Mizuno N S, Derr RF. Liver RNA in aminonucleoside nephrosis in rats. Life Sci 1971; 10(Part II)781–789
   Google Scholar
• Alexander C S, Nagasawa H T, Filbin D. Distribution and excretion of aminonucleoside-8-C14 in normal and nephrotic rats. Proc Soc Exp Biol Med 1962; 111: 521–526
   PubMedGoogle Scholar
• Derr R F, Alexander C S, Nagasawa HT. Metabolism of puromycin aminonucleoside in the normal, “pre-nephrotic,” and nephrotic rat. Proc Soc Exp Biol Med 1967; 125: 248–252
   PubMed Web of Science ®Google Scholar
• Nagasawa H T, Swingle K F, Alexander CS. Metabolism of aminonucleoside-8-14C in the rat and guinea pig. Biochem Pharmacol 1967; 16: 2211–2219
   PubMedGoogle Scholar
• Garber D W, Gottlieb B A, Marsh J B, Sparks CE. Catabolism of very low density lipoproteins in experimental nephrosis. J Clin Invest 1984; 74: 1375–1383
   PubMedGoogle Scholar
• Staprans Y, Felts J M, Couser WG. Glycosaminoglycans and chylomicron metabolism in control and nephrotic rats. Metabolism 1987; 36: 496–501
   PubMedGoogle Scholar
• Katz J, Bonorris G, Sellers AL. Albumin metabolism in aminonucleoside nephrotic rats. J Lab Clin Med 1963; 62: 910–934
   PubMedGoogle Scholar
• Pedraza-Chaverrí J, Huberman A. Actinomycin D blocks the hepatic functional albumin mRNA increase in aminonucleoside nephrotic rats. Nephron 1991; 59: 648–650
   PubMedGoogle Scholar
• Ibarra-Rubio M E, Pedraza-Chaverrí J, Panduro A. Differential regulation in the expression of hepatic genes in nephrotic and pair-fed rats. Nephron 1993; 65: 119–124
   PubMedGoogle Scholar
• Tarugi P, Calandra S, Chan L. Changes in apolipoprotein A-I mRNA level in the liver of rats with experimental nephrotic syndrome. Biochim Biophys Acta 1986; 868: 51–61
   PubMedGoogle Scholar
• Sun X, Martin V, Weiss R H, Kaysen GA. Selective transcriptional augmentation of hepatic gene expression in the rat with Heymann nephritis. Am J Physiol 1993; 264: F441–F447
   PubMed Web of Science ®Google Scholar
• Sun X, Jones H, Jr., Joles J A, Van Tol A, Kaysen GA. Apolipoprotein gene expression in analbuminemic rats and in rats with Heymann nephritis. Am J Physiol 1992; 262: F755–F761
   Google Scholar
• Olson J L, Rennke H G, Venkatachalam MA. Alterations in the charge and size selectivity barrier of the glomerular filter in aminonucleoside nephrosis in rats. Lab Invest 1981; 44: 271–279
   PubMed Web of Science ®Google Scholar
• Farquhar M G, Palade GE. Glomerular permeability. II. Ferritin transfer across the glomerular capillary wall in nephrotic rats. J Exp Med 1961; 114: 699–741
   PubMedGoogle Scholar
• Venkatachalam M A, Cotran R S, Karnovsky MJ. An ultrastructural study on glomerular permeability in aminonucleoside nephrosis using catalase as tracer protein. J Exp Med 1970; 132: 1168–1180
   PubMedGoogle Scholar
• Ota Z, Shikata K, Ota K. Nephrotic tunnels in glomerular basement membrane as revealed by a new electron microscopic method. J Am Soc Nephrol 1994; 4: 1965–1973
   PubMedGoogle Scholar
• Vaziri N D, Gonzales E C, Shayestehfar B, Barton CH. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome. J Lab Clin Med 1994; 124: 118–124
   PubMedGoogle Scholar